These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18279775)

  • 1. Overview of emerging pharmacologic agents for acute heart failure syndromes.
    De Luca L; Mebazaa A; Filippatos G; Parissis JT; Böhm M; Voors AA; Nieminen M; Zannad F; Rhodes A; El-Banayosy A; Dickstein K; Gheorghiade M
    Eur J Heart Fail; 2008 Feb; 10(2):201-13. PubMed ID: 18279775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of new medical treatments for acute decompensated heart failure.
    Teerlink JR
    Heart Fail Monit; 2002; 2(4):129-37. PubMed ID: 12634887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for the management of decompensated heart failure: from bench to bedside.
    deGoma EM; Vagelos RH; Fowler MB; Ashley EA
    J Am Coll Cardiol; 2006 Dec; 48(12):2397-409. PubMed ID: 17174176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of current noninodilator therapies for acute heart failure syndromes.
    Stough WG; O'Connor CM; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pharmacologic therapies for acute heart failure.
    Tavares M; Rezlan E; Vostroknoutova I; Khouadja H; Mebazaa A
    Crit Care Med; 2008 Jan; 36(1 Suppl):S112-20. PubMed ID: 18158470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology: an update.
    Liu H; Fox CJ; Zhang S; Kaye AD
    Anesthesiol Clin; 2010 Dec; 28(4):723-38. PubMed ID: 21074748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of new agents for acute heart failure syndromes.
    Gheorghiade M; Teerlink JR; Mebazaa A
    Am J Cardiol; 2005 Sep; 96(6A):68G-73G. PubMed ID: 16181825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
    Shah SJ; Blair JE; Filippatos GS; Macarie C; Ruzyllo W; Korewicki J; Bubenek-Turconi SI; Ceracchi M; Bianchetti M; Carminati P; Kremastinos D; Grzybowski J; Valentini G; Sabbah HN; Gheorghiade M;
    Am Heart J; 2009 Jun; 157(6):1035-41. PubMed ID: 19464414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trials with levosimendan.
    Mebazaa A; Barraud D; Welschbillig S
    Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
    Berger R; Moertl D; Huelsmann M; Bojic A; Ahmadi R; Heissenberger I; Pacher R
    Eur J Heart Fail; 2007 Feb; 9(2):202-8. PubMed ID: 16859992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer approaches to the pharmacological management of heart failure.
    Rauch H; Motsch J; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):75-81. PubMed ID: 16547437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic choices in the management of acute congestive heart failure.
    Young JB
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S19-24. PubMed ID: 12439358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR
    Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection: a new paradigm in the management of acute heart failure syndromes.
    Maytin M; Colucci WS
    Am J Cardiol; 2005 Sep; 96(6A):26G-31G. PubMed ID: 16181820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM; Akhter MW
    Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan: a new option in acute cardiac failure.
    Holley AD; Ziegenfuss M
    Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract]   [Full Text] [Related]  

  • 20. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
    Jain P; Massie BM; Gattis WA; Klein L; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S3-17. PubMed ID: 12594447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.